Extracellular vesicles-Mediators of opioid use disorder?
Recommended Citation
Morris DC, Zacharek A, Zhang ZG, and Chopp M. Extracellular vesicles-Mediators of opioid use disorder? Addict Biol 2023; 28(12):e13353.
Document Type
Article
Publication Date
12-1-2023
Publication Title
Addiction biology
Abstract
Opioid use disorder (OUD) is a growing health emergency in the United States leading to an epidemic of overdose deaths. OUD is recognized as an addictive brain disorder resulting in psychological, cognitive and behavioural dysfunction. These observed clinical dysfunctions are a result of cellular changes that occur in the brain. Derangements in inflammation, neurogenesis and synaptic plasticity are observed in the brains of OUD patients. The mechanisms of these derangements are unclear; however, extracellular vesicles (EVs), membrane bound particles containing protein, nucleotides and lipids are currently being investigated as agents that invoke these cellular changes. The primary function of EVs is to facilitate intercellular communication by transfer of cargo (protein, nucleotides and lipids) between cells; however, changes in this cargo have been observed in models of OUD suggesting that EVs may be agents promoting the observed cellular derangements. This review summarizes evidence that altered cargo of EVs, specifically protein and miRNA, in models of OUD promote impairments in neurons, astrocytes and microglial cells. These findings support the premise that opioids alter EVs to detrimentally affect neuro-cellular function resulting in the observed addictive, psychological and neurocognitive deficits in OUD patients.
Medical Subject Headings
Humans; United States; MicroRNAs; Opioid-Related Disorders; Extracellular Vesicles; Nucleotides; Lipids
PubMed ID
38017641
Volume
28
Issue
12
First Page
13353
Last Page
13353